Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Eli Lilly Stock Slips Lower As FDA Rejects Fast Track Approval For Alzheimer's Drug

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.

The Street

GPs blast 'out-of-control' pharmacists

The peak bodies for GPs and pharmacy owners have traded insults, including accusations of being "out of control" and whipping up a media frenzy.

AAP

Chemicals for possible fentanyl production seized in Arizona

U.S. agents in southern Arizona say they seized up to 440 pounds of what they suspect is a precursor chemical often used to manufacture the dangerous drug fentanyl

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Incyte Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

Incyte shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Investors Business Daily

Neogen Stock Earns Relative Strength Rating Upgrade

A Relative Strength Rating upgrade for Neogen shows improving technical performance. Will it continue?

Investors Business Daily

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes

Novocure announced a series of exec changes on Thursday as investor debate continues to haunt its recent study. NVCR stock tumbled again.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Sainsbury's to lose 237 in-store pharmacies across UK

LloydsPharmacy is ending its services with the supermarket, but official closure dates are yet to be confirmed

Manchester Evening News

Frost renews call to exclude medicines from Northern Ireland Brexit rules

Industry figures warn of supply ‘cliff edge’ when new regulations come into effect in December

The Guardian - UK

Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength Rating Benchmark

Vertex Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Abortion pill sites give Google data

Law enforcement can potentially use this data to prosecute people who end their pregnancies with medication

Salon

W.Va. announces $83 million opioid settlement with Walgreens

West Virginia has settled for $83 million with Walgreens for the pharmacy store chain’s role in perpetuating the opioid crisis in the U.S. state with the most per capita overdose deaths

The Independent UK

Cassava Sciences Stock Shows Big Jump In Its Relative Strength Rating

Cassava Sciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 87.

Investors Business Daily

Scottish cannabis farm secures £2 million in bid to become UK leader

SCOTLAND'S first medical cannabis production facility has secured £2 million in private investment to become one of the largest producers in the UK…

The National (Scotland)

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

FDA suit accuses Florida company of making and selling ‘adulterated’ drugs

The Food and Drug Administration has filed a lawsuit accusing a Boca Raton pharmaceutical manufacturer of selling “adulterated” drugs and failure to correct violations cited by the FDA in 2018.

Tribune News Service

How much faster can computers get? UC San Diego is leading a $50M effort to find out

A group of 10 universities led by the University of California, San Diego is undertaking a $50.5 million effort to greatly improve the speed and efficiency of computers, work that could do everything from make drug discovery faster to create better weather forecasts.

The Street

Moderna Stock Leaps On Positive Data From Late-Stage RSV Vaccine Trial

"We are committed to developing a portfolio of respiratory mRNA vaccines to target the most significant viruses causing respiratory disease, including COVID-19, influenza, and human metapneumovirus," said CEO Stéphane Bancel.

Irish Mirror

Pharmacist recommends specific test for vulnerable people as Ireland experiences 'triple surge' of illness

There is fear that Ireland may have many more cases to come

Get all your
news in one place.

100’s of premium titles.
One news app.

Bangkok Post

Innobic allocates B1bn for investments

Innobic (Asia), the life science arm of national oil and gas conglomerate PTT Plc, plans to spend 1 billion baht in capital expenditure this year to support cancer medicine and plant-based protein factory development projects.

Investors Business Daily

Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market

Moderna stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective.

Investors Business Daily

Organon Stock Scores Market Leadership With Jump To 83 RS Rating

Organon sees its Relative Strength Rating reach the 80-plus level.

ABC News

Canberra's pill-testing results confirm that 'ketamine' is often another drug

The first five months of the ACT's controversial drug-checking trial show only 53 per cent of substances thought to be ketamine actually are.

AFP

Pfizer to sell more drugs at cost to poor nations

Washington (AFP) - US pharmaceutical giant Pfizer announced on Tuesday that it will greatly expand the number of medicines and vaccines it sells on a not-for-profit basis to the world's poorest countries.

Investors Business Daily

Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares

Pfizer stock needs a "Covid reset," a Wells Fargo analyst said as he downgraded shares this week. In response, shares slipped Tuesday.

The Conversation

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works

Media outlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.

1 … 51 52 53 54

People

Buranin Rattanasombat

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.